Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients.

Source:http://linkedlifedata.com/resource/pubmed/id/18486984

Download in:

View as

General Info

PMID
18486984